Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Inventory (2017 - 2025)

Historic Inventory for ImmunityBio (IBRX) over the last 5 years, with Q3 2025 value amounting to $6.7 million.

  • ImmunityBio's Inventory rose 24233.91% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 24233.91%. This contributed to the annual value of $8.3 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that ImmunityBio reported Inventory of $6.7 million as of Q3 2025, which was up 24233.91% from $6.6 million recorded in Q2 2025.
  • ImmunityBio's Inventory's 5-year high stood at $8.4 million during Q1 2025, with a 5-year trough of $1.8 million in Q2 2024.